4.4 Review

Role of ER Stress Mediated Unfolded Protein Responses and ER Stress Inhibitors in the Pathogenesis of Inflammatory Bowel Disease

Journal

DIGESTIVE DISEASES AND SCIENCES
Volume 67, Issue 12, Pages 5392-5406

Publisher

SPRINGER
DOI: 10.1007/s10620-022-07467-y

Keywords

Inflammatory bowel disease; Endoplasmic reticulum stress; Unfolded protein response; ER stress inhibitors; Therapy

Funding

  1. Chettinad Academy of Research and Education (CARE)

Ask authors/readers for more resources

Endoplasmic reticulum stress, caused by cellular mechanism, may contribute to the pathogenesis of inflammatory bowel disease by disrupting protein synthesis, inducing epithelial cell apoptosis, and triggering inflammatory reactions in the gut. Pharmacological intervention to restore unfolded protein response balance in the endoplasmic reticulum could be a novel therapeutic approach for treating inflammatory bowel diseases.
Previous investigations have increased the knowledge about the pathological processes of inflammatory bowel diseases. Besides the complex organization of immune reactions, the mucosal epithelial lining has been recognized as a crucial regulator in the commencement and persistence of intestinal inflammation. As the intestinal epithelium is exposed to various environmental factors, the intestinal epithelial cells are confronted with diverse cellular stress conditions. In eukaryotic cells, an imbalance in the endoplasmic reticulum (ER) might cause aggregation of unfolded or misfolded proteins in the lumen of ER, a condition known as endoplasmic reticulum stress. This cellular mechanism stimulates the unfolded protein response (UPR), which elevates the potential of the endoplasmic reticulum protein folding, improves protein production and its maturation, and also stimulates ER-associated protein degradation. Current analyses reported that in the epithelium, the ER stress might cause the pathogenesis of inflammatory bowel disease that affects the synthesis of protein, inducing the apoptosis of the epithelial cell and stimulating the proinflammatory reactions in the gut. There have been significant efforts to develop small molecules or molecular chaperones that will be potent in ameliorating ER stress. The restoration of UPR balance in the endoplasmic reticulum via pharmacological intervention might be a novel therapeutic approach for the treatment of inflammatory bowel diseases (IBDs). This review provides novel insights into the role of chemical chaperone UPR modulators to modify ER stress levels. We further discuss the future directions/challenges in the development of therapeutic strategies for IBDs by targeting the ER stress. Graphical Abstract Figure depicting the role of endoplasmic reticulum stress-mediated inflammatory bowel disease and the therapeutic role of endoplasmic reticulum stress inhibitors in alleviating the diseased condition. [GRAPHICS]

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available